Published in J Bone Miner Res on December 01, 2009
Marrow fat metabolism is linked to the systemic energy metabolism. Bone (2011) 1.23
Adiponectin inhibits osteoclastogenesis and bone resorption via APPL1-mediated suppression of Akt1. J Biol Chem (2011) 1.08
Adipokines and the risk of fracture in older adults. J Bone Miner Res (2011) 1.00
Adiponectin and bone mass density: The InCHIANTI study. Bone (2010) 0.96
The effects of adiponectin and leptin on changes in bone mineral density. Osteoporos Int (2011) 0.89
Novel adipokines and bone metabolism. Int J Endocrinol (2013) 0.87
Relationship between leptin, adiponectin, bone mineral density, and measures of adiposity among pre-menopausal Hispanic and Caucasian women. Endocr Res (2010) 0.87
Adiponectin is a candidate biomarker of lower extremity bone density in men with chronic spinal cord injury. J Bone Miner Res (2014) 0.86
Serum adiponectin and bone mineral density in male hemodialysis patients. Osteoporos Int (2011) 0.82
The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2009) 0.82
The association between aortic calcification and fracture risk in postmenopausal women in China: the prospective Chongqing osteoporosis study. PLoS One (2014) 0.79
Waning predictive value of serum adiponectin for fracture risk in elderly men: MrOS Sweden. Osteoporos Int (2014) 0.78
The alliance of mesenchymal stem cells, bone, and diabetes. Int J Endocrinol (2014) 0.78
Hormone-sensitive lipase-knockout mice maintain high bone density during aging. FASEB J (2011) 0.76
Vertebral bone marrow fat, bone mineral density and diabetes: The Osteoporotic Fractures in Men (MrOS) study. Bone (2017) 0.75
Obesity is a concern for bone health with aging. Nutr Res (2017) 0.75
Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected Women. J Acquir Immune Defic Syndr (2016) 0.75
Bone health as a function of adipokines and vitamin D pattern in elderly patients. Rejuvenation Res (2013) 0.75
Expression of adiponectin receptors in human and rat intervertebral disc cells and changes in receptor expression during disc degeneration using a rat tail temporary static compression model. J Orthop Surg Res (2016) 0.75
The relationship between circulating adiponectin, leptin and vaspin with bone mineral density (BMD), arterial calcification and stiffness: a cross-sectional study in post-menopausal women. J Endocrinol Invest (2017) 0.75
Prevalence of morphometric vertebral fractures in old men and the agreement between different methods in the city of Recife, Brazil. Rheumatol Int (2014) 0.75
Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res (1993) 10.98
Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia (2003) 5.91
Adiponectin: more than just another fat cell hormone? Diabetes Care (2003) 3.30
Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study. J Clin Endocrinol Metab (2006) 2.34
Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab (2008) 2.30
Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone (2003) 2.17
Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res (2006) 2.01
Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns. J Clin Endocrinol Metab (2003) 1.84
Independent circadian and sleep/wake regulation of adipokines and glucose in humans. J Clin Endocrinol Metab (2005) 1.81
Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood) (2008) 1.76
Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem (2003) 1.70
Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab (2007) 1.63
Ethnic differences in adiponectin levels. Metabolism (2004) 1.45
Diabetes and hypertension in a community of older adults. Am J Epidemiol (1981) 1.41
Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther (1999) 1.35
Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American, and white women. Obesity (Silver Spring) (2007) 1.32
Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res (2004) 1.26
The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) (2005) 1.21
The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab (2008) 1.08
The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int (2008) 1.08
Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta (2007) 1.04
Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab (2007) 1.03
Adiponectin is associated with low bone mineral density in elderly men. Eur J Endocrinol (2008) 1.03
Early and rapid bone mineral density loss of the proximal femur in men. J Clin Endocrinol Metab (2007) 1.00
Relation between adiponectin and bone mineral density in elderly post-menopausal women: role of body composition, leptin, insulin resistance, and dehydroepiandrosterone sulfate. J Endocrinol Invest (2008) 1.00
Serum adiponectin in elderly men does not correlate with fracture risk. J Clin Endocrinol Metab (2008) 0.99
The transition to menopause reinforces adiponectin production and its contribution to improvement of insulin-resistant state. Clin Endocrinol (Oxf) (2007) 0.89
Relationship of body composition and circulatory adiponectin to bone mineral density in young premenopausal women. J Med Assoc Thai (2006) 0.85
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care (2007) 8.43
Birth weight and risk of type 2 diabetes: a systematic review. JAMA (2008) 6.73
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study. BMJ (2005) 5.34
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Low serum testosterone and mortality in older men. J Clin Endocrinol Metab (2007) 4.27
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. J Natl Cancer Inst (2004) 4.09
Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med (2004) 3.93
Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91
Frailty in older men: prevalence, progression, and relationship with mortality. J Am Geriatr Soc (2007) 3.15
Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA (2002) 3.13
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes (2005) 2.80
Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care (2007) 2.71
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2002) 2.69
Testosterone and estradiol among older men. J Clin Endocrinol Metab (2005) 2.63
Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation (2008) 2.56
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr (2008) 2.55
Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics (2009) 2.46
Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes (2005) 2.46
Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol (2013) 2.44
Ethnic differences in visceral adipose tissue and type 2 diabetes: Filipino, African-American, and white women. Obes Res (2005) 2.44
Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ Cardiovasc Qual Outcomes (2012) 2.43
Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol (2002) 2.41
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2003) 2.40
A1C and diabetes diagnosis: The Rancho Bernardo Study. Diabetes Care (2009) 2.36
The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci (2006) 2.35
Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care (2002) 2.28
Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. J Am Coll Cardiol (2008) 2.26
Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med (2007) 2.17
Report of a National Heart, Lung, And Blood Institute Workshop: heterogeneity in cardiometabolic risk in Asian Americans In the U.S. Opportunities for research. J Am Coll Cardiol (2010) 2.15
Vitamin D deficiency in older men. J Clin Endocrinol Metab (2009) 2.13
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10
Type 2 diabetes and metabolic syndrome in Filipina-American women : a high-risk nonobese population. Diabetes Care (2002) 2.10
Decreased slow wave sleep increases risk of developing hypertension in elderly men. Hypertension (2011) 2.09
Sex differences in the association between proinsulin and intact insulin with coronary heart disease in nondiabetic older adults: the Rancho Bernardo Study. Circulation (2002) 2.06
Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism (2002) 2.04
Effect of postmenopausal hormone therapy on cognitive function: the Heart and Estrogen/progestin Replacement Study. Am J Med (2002) 2.02
Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care (2009) 1.95
Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Arch Intern Med (2004) 1.95
Predictors of non-spine fracture in elderly men: the MrOS study. J Bone Miner Res (2007) 1.93
Hyperkyphotic posture and risk of future osteoporotic fractures: the Rancho Bernardo study. J Bone Miner Res (2005) 1.89
Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation (2011) 1.88
Walking decreased risk of cardiovascular disease mortality in older adults with diabetes. J Clin Epidemiol (2006) 1.86
Hyperkyphotic posture predicts mortality in older community-dwelling men and women: a prospective study. J Am Geriatr Soc (2004) 1.86
Association of adiponectin with coronary heart disease and mortality: the Rancho Bernardo study. Am J Epidemiol (2006) 1.85
Relation of 25-hydroxyvitamin D and parathyroid hormone levels with metabolic syndrome among US adults. Eur J Endocrinol (2008) 1.84
Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. J Am Coll Cardiol (2012) 1.84
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol (2005) 1.83
Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int (2005) 1.82
Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol (2011) 1.81
High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) study in Sweden. J Am Coll Cardiol (2011) 1.81
Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause (2009) 1.80
Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health In Aging (SOPHIA) Study. Menopause (2003) 1.77
Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmenopausal Estrogen/Progestin Intervention Trial. J Clin Endocrinol Metab (2003) 1.76
Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res (2004) 1.76
Predictors of heart failure among women with coronary disease. Circulation (2004) 1.74
Endogenous testosterone levels, physical performance, and fall risk in older men. Arch Intern Med (2006) 1.72
Retinol intake and bone mineral density in the elderly: the Rancho Bernardo Study. J Bone Miner Res (2002) 1.70
The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab (2004) 1.70
Sexual activity and satisfaction in healthy community-dwelling older women. Am J Med (2012) 1.70
Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med (2003) 1.68
Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Obstet Gynecol (2004) 1.68
Gender differences in nighttime sleep and daytime napping as predictors of mortality in older adults: the Rancho Bernardo study. Sleep Med (2012) 1.67
Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res (2002) 1.58
Hyperkyphotic posture and poor physical functional ability in older community-dwelling men and women: the Rancho Bernardo study. J Gerontol A Biol Sci Med Sci (2005) 1.57
Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr (2008) 1.56
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. J Natl Cancer Inst (2008) 1.56
Is diabetes mellitus a heart disease equivalent in women? Results from an international study of postmenopausal women in the Raloxifene Use for the Heart (RUTH) Trial. Circ Cardiovasc Qual Outcomes (2013) 1.55
Hyperkyphotic posture and risk of injurious falls in older persons: the Rancho Bernardo Study. J Gerontol A Biol Sci Med Sci (2007) 1.54
Lower urinary tract symptoms increase the risk of falls in older men. BJU Int (2009) 1.53
Race and ethnic variation in proximal femur structure and BMD among older men. J Bone Miner Res (2008) 1.53
Bone mineral density and clinical hand osteoarthritis in elderly men and women: the Rancho Bernardo study. J Rheumatol (2002) 1.52
A prospective study of albuminuria and cognitive function in older adults: the Rancho Bernardo study. Am J Epidemiol (2010) 1.52
The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab (2009) 1.52
Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men. BJU Int (2009) 1.52
BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS). J Bone Miner Res (2011) 1.51
Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause (2011) 1.51
Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care (2006) 1.50
Reductions in glucose among postmenopausal women who use and do not use estrogen therapy. Menopause (2013) 1.50
Prevalence and factor analysis of metabolic syndrome in an urban Korean population. Diabetes Care (2004) 1.50
Kidney function and cognitive performance and decline in older men. J Am Geriatr Soc (2008) 1.48
Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years. Urology (2008) 1.48
An approach to identifying osteopenic women at increased short-term risk of fracture. Arch Intern Med (2004) 1.48
Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care (2008) 1.48
Association between the ankle-brachial index and carotid intimal medial thickness in the Rancho Bernardo Study. Am J Cardiol (2006) 1.47
When is it appropriate to prescribe postmenopausal hormone therapy? Menopause (2006) 1.46
Body mass index and quality of well-being in a community of older adults. Am J Prev Med (2004) 1.46
The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials (2014) 1.46
Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes (2007) 1.45
Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab (2006) 1.44
Serum 25-hydroxyvitamin D levels and rate of hip bone loss in older men. J Clin Endocrinol Metab (2009) 1.44
Voluntary weight reduction in older men increases hip bone loss: the osteoporotic fractures in men study. J Clin Endocrinol Metab (2005) 1.44